出版物 打印 Sperduto W, Voss MM, Laughlin B, Toesca DAS, Wong WW, Keole SR, Rwigema JM, Yu NY, Schild SE, James SE, Daniels TB, DeWees TA, Vargas CE. Five-Year Prostate-Specific Membrane Antigen Positron Emission Tomography-Based Outcomes of Spot-Scanning Proton Radiation Therapy for Localized Prostate Cancer: A Single Institution Experience. Adv Radiat Oncol. 2024 Nov; 9 (11):101639 Epub 2024 Sept 18 View PubMed Tegtmeier RC, Clouser EL, Laughlin BS, Santos Toesca DA, Flakus MJ, Bashir S, Kutyreff CJ, Hobbis D, Harrington DP, Smetanick JL, Yu NY, Vargas CE, James SE, Rwigema JM, Rong Y. Evaluation of knowledge-based planning models for male pelvic CBCT-based online adaptive radiotherapy on conventional linear accelerators. J Appl Clin Med Phys. 2024 Sep; 25 (9):e14464 Epub 2024 July 19 View PubMed James SE, Riggan KA, Halyard M, Kelly M, Cobran E, Allyse MA. The "Strong Black Woman" Paradox: Insights from a Cohort of Black Breast and Ovarian Cancer Patients and Family Members. J Racial Ethn Health Disparities. 2024 Jan 8 Epub 2024 Jan 08 View PubMed Rousseau A, Riggan KA, Halyard M, James SE, Kelly M, Phillips D, Allyse MA. Cancer Screening Experiences of Black Breast and Ovarian Cancer Patients and Family Members. J Community Health. 2023 Oct; 48 (5):882-888 Epub 2023 May 23 View PubMed Kang Y, Bues M, Halyard MY, McGee LA, Vern-Gross TZ, Wong WW, Keole SR, Vargas C, James SE, Ahmed SK, Archuleta JP, Ridgway AK, Lara PR, Fatyga M. Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization. Radiat Oncol. 2023 Sep 22; 18 (1):157 Epub 2023 Sept 22 View PubMed Riggan KA, Rousseau A, Halyard M, James SE, Kelly M, Phillips D, Allyse MA. "There's not enough studies": Views of black breast and ovarian cancer patients on research participation. Cancer Med. 2023 Apr; 12 (7):8767-8776 Epub 2023 Jan 16 View PubMed Pepin K, Grimm R, Kargar S, Howe BM, Fritchie K, Frick M, Wenger D, Okuno S, Ehman R, McGee K, James S, Laack N, Herman M, Pafundi D. Soft Tissue Sarcoma Stiffness and Perfusion Evaluation by MRE and DCE-MRI for Radiation Therapy Response Assessment: A Technical Feasibility Study. Biomed Phys Eng Express. 2019 Jul; 5 (4) Epub 2019 May 22 View PubMed Lester SC, Lin SH, Chuong M, Bhooshan N, Liao Z, Arnett AL, James SE, Evans JD, Spears GM, Komaki R, Haddock MG, Mehta MP, Hallemeier CL, Merrell KW. A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients. Int J Radiat Oncol Biol Phys. 2017 Jul 15; 98 (4):820-828 Epub 2017 Feb 20 View PubMed Lin SH, Merrell KW, Shen J, Verma V, Correa AM, Wang L, Thall PF, Bhooshan N, James SE, Haddock MG, Suntharalingam M, Mehta MP, Liao Z, Cox JD, Komaki R, Mehran RJ, Chuong MD, Hallemeier CL. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol. 2017 Jun; 123 (3):376-381 Epub 2017 Apr 25 View PubMed Arnett ALH, Merrell KW, Martin Macintosh E, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL. Utility of (18)F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation. J Thorac Oncol. 2017 Jan; 12 (1):121-128 Epub 2016 Aug 26 View PubMed Biswas T, Efird JT, Prasad S, James SE, Walker PR, Zagar TM. Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC. Clin Breast Cancer. 2016 Jun; 16: (3)212-6. View PubMed Prasad S, Efird JT, James SE, Walker PR, Zagar TM, Biswas T. Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women. Springerplus. 2016; 5 (1):756 Epub 2016 June 17 View PubMed He Y, Han JR, Chang O, Oh M, James SE, Lu Q, Seo YW, Kim H, Kim K. 14-3-3varepsilon/zeta Affects the stability of delta-catenin and regulates delta-catenin-induced dendrogenesis. FEBS Open Bio. 2013; 3:16-21. View PubMed James SE, Dunham M, Carrion-Jones M, Murashov A, Lu Q. Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin. Neurotoxicology. 2010 Mar; 31: (2)188-94. View PubMed Dunham MW, James SE, Lever TE, Lu Q, Carrion-Jones MJ. Methodology to obtain a mixed sural nerve recording in mice. Am J Phys Med Rehabil. 2009 Jul; 88: (7)542-6. View PubMed James SE, Burden H, Burgess R, Xie Y, Yang T, Massa SM, Longo FM, Lu Q. Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants. Neurotoxicology. 2008 Jul; 29: (4)605-12. View PubMed Kim H, Han JR, Park J, Oh M, James SE, Chang S, Lu Q, Lee KY, Ki H, Song WJ, Kim K. Delta-catenin-induced dendritic morphogenesis. An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation. J Biol Chem. 2008 Jan 11; 283: (2)977-87. View PubMed PST-20511561 主页 出版物